Pharmacological treatments and complementary alternative products: a new study confirms the efficacy of adaptive treatments to quit smoking.

A new analysis conducted between Italy and USA has evaluated the effectiveness of the currently available methods to quit smoking, concluding that these products, which include both pharmaceutical cessation products…

Continue ReadingPharmacological treatments and complementary alternative products: a new study confirms the efficacy of adaptive treatments to quit smoking.

Quit Like Sweden: “We need solutions to a century-old problem”

Present at the event, Jeffrey Zamora, President of ASOVAPE Costa Rica and Project Leader of the Veritas project, a research conducted by CoEHAR which will try to identify if there are any harmful effects of long-term regular vaping on respiratory health or other endpoints for people who never smoked.

Continue ReadingQuit Like Sweden: “We need solutions to a century-old problem”

CoEHAR, No Tobacco Day 2024: youth in the spotlight

The meeting will be held on Thursday, May 30, at 8:30 AM in the Aula Magna of the Biological Tower at the University of Catania. The topics discussed will range from oral to sexual health, from sociology to marketing, from diagnosis to clinical treatment, also covering innovative solutions and new tools provided through the use of artificial intelligence.

Continue ReadingCoEHAR, No Tobacco Day 2024: youth in the spotlight

Global Action to End Smoking: the US nonprofit organization new commitment to support smoking cessation

The global action to end smoking grantmaking will continue to focus on advancing health and science research for cutting-edge smoking cessation and reduced-risk solutions, with a particular focus on marginalized communities and low- and middle-income countries where smoking is most widespread.

Continue ReadingGlobal Action to End Smoking: the US nonprofit organization new commitment to support smoking cessation

The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.

Continue ReadingThe first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

CoEHAR in China to open a new research front in risk reduction: impotence and infertility under the spotlight

Activities at the Center of Excellence for the acceleration of Harm Reduction at the University of Catania (CoEHAR) are in full swing. After presenting to the press the first 9 approved…

Continue ReadingCoEHAR in China to open a new research front in risk reduction: impotence and infertility under the spotlight